Grant Sean
- SEC CIK
- 0001872792
In the past year, 1 open-market sale filing worth $207.8K and no purchases.
Current role at each company
- VERA Vera Therapeutics, Inc.CHIEF FINANCIAL OFFICERas of Feb 25, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $207.8K
- 1 filing
- Net
- −$207.8K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Grant Sean as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 (view filing) | Feb 23 | 2 days | Grant SeanCHIEF FINANCIAL OFFICER | SSaleClass A Common Stock | −4.95K | $41.98 | −$207.8K | −4.2%114.2K after | |
| Apr 5, 2024 (view filing) | Apr 3 | 2 days | Grant SeanCHIEF FINANCIAL OFFICER | SSaleClass A Common Stock | −99.8K | $39.61 | −$3.95M | −60.1%66.3K after | 4 lots |
| Apr 5, 2024 (view filing) | Apr 3 | 2 days | Grant SeanCHIEF FINANCIAL OFFICER | SSaleClass A Common Stock | −18.6K | $39.42 | −$735.2K | −78.9%5.00K after | 15 lots |
| Jun 23, 2023 (view filing) | Jun 23 | Same day | Grant SeanChief Financial Officer | PPurchaseClass A Common Stock | +5.00K | $16.60 | +$83.0K | +504.0%5.99K after | |
| Feb 17, 2023 (view filing) | Feb 6 | 11 days | Grant SeanChief Financial Officer | PPurchaseClass A Common Stock | +14.3K | $7.00 | +$100.0K | +40.1%49.9K after | Amended |
| Jun 16, 2022 (view filing) | Jun 15 | 1 day | Grant SeanChief Financial Officer | PPurchaseClass A Common Stock | +5.00K | $13.60 | +$68.0K | New position992 after | 4 lots |